Aclidinium inhibits human lung fibroblast to myofibroblast transition.
about
Aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseLong-acting muscarinic receptor antagonists for the treatment of chronic airway diseasesRelation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patientsThe analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytesmAChRs activation induces epithelial-mesenchymal transition on lung epithelial cellsRestenosis after balloon valvuloplasty in a dog with pulmonary stenosis.Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects.Combination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in a guinea pig model of chronic asthma.Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt-Hogg-Dubé syndrome.Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processesMuscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease.Clinical potential of aclidinium bromide in chronic obstructive pulmonary diseaseAnticholinergics/antimuscarinic drugs in asthma.Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?Cross-talk between transforming growth factor-β₁ and muscarinic M₂ receptors augments airway smooth muscle proliferation.Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients.The JAK2 pathway is activated in idiopathic pulmonary fibrosis.Muscarinic Receptor Antagonists.Fibroblast-to-myofibroblast transition in bronchial asthma
P2860
Q22306019-F0DA1866-F532-4CE0-AFF6-B40C630BCEA1Q27022636-BD3A692D-FCAA-44CC-806D-15E744B6D518Q30460434-49E99902-DCE1-4495-A431-C9B52C994749Q34460791-6C22D9EF-11EA-4AE3-877D-FB2967A4AFA1Q35134213-16131DDE-4D26-40F7-9328-5C15654E6002Q35147113-30BC2FB8-A1E0-438C-B0A6-E1D630B34FC6Q35216188-553AAD4E-302F-4AD2-8F6D-901FBA4E413DQ36440308-330A30B2-65E5-4054-A572-1078A7E5EFBEQ36549776-44135CE4-C819-4C9E-BFE9-8FA7D825C45DQ37419031-80D3B903-D8A9-4559-8F54-10BD2C7380B9Q37694052-D527445F-5664-4161-8F4A-80606F4322AEQ38199533-87D5533D-4179-4811-BCFF-3A544D886173Q38223379-DC763742-46F3-45BD-80DA-11B87F921481Q38256783-2C437D13-C563-4AED-8547-41F3205A0856Q38270131-6E89FE25-58CD-4984-A592-7E953EE88269Q39187121-FB0F725D-664A-4F04-8EAE-5204F5552A5FQ40090191-FD257771-045D-43F8-90D1-02A006E59104Q42371634-2058D750-9A38-477F-B2AD-2A8787D4AF13Q48509995-E04F0491-178B-402C-979B-1E1E92517C90Q51432583-C859D6DB-A675-469B-8776-E48774A363D8Q58787537-6BE93030-8BA8-4D73-908A-85917453A126
P2860
Aclidinium inhibits human lung fibroblast to myofibroblast transition.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Aclidinium inhibits human lung fibroblast to myofibroblast transition.
@en
type
label
Aclidinium inhibits human lung fibroblast to myofibroblast transition.
@en
prefLabel
Aclidinium inhibits human lung fibroblast to myofibroblast transition.
@en
P2093
P2860
P1433
P1476
Aclidinium inhibits human lung fibroblast to myofibroblast transition
@en
P2093
Adela Serrano
Javier Milara
Julio Cortijo
Montserrat Miralpeix
Teresa Peiró
P2860
P304
P356
10.1136/THORAXJNL-2011-200376
P407
P577
2011-09-28T00:00:00Z